The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지

The Clinical study in 60 cases for breast cancer patients on the effects by Hnagamdan(抗癌丹)

항암단(抗癌丹)을 투여한 유방암(乳房癌) 환자(患者) 60례(例)에 대한 임상보고(臨床報告)

  • Choi, Byung-Lyul (Department of Internal Medicine, Oriental Hospital of Daejeon University) ;
  • Lee, Yong-Yeon (Department of Internal Medicine, Oriental Hospital of Daejeon University) ;
  • Yoo, Hwa-Seung (Department of Internal Medicine, Oriental Hospital of Daejeon University) ;
  • Seo, Sang-Hoon (Department of Internal Medicine, Oriental Hospital of Daejeon University) ;
  • Choi, Woo-Jin (Department of Internal Medicine, Oriental Hospital of Daejeon University) ;
  • Cho, Jung-Hyo (Department of Internal Medicine, Oriental Hospital of Daejeon University) ;
  • Lee, Yeon-Weol (Department of Internal Medicine, Oriental Hospital of Daejeon University) ;
  • Son, Chang-Kyu (Department of Internal Medicine, Oriental Hospital of Daejeon University) ;
  • Cho, Chong-Kwan (Department of Internal Medicine, Oriental Hospital of Daejeon University) ;
  • Song, Kee-Cheol (Department of Internal Medicine, Oriental Hospital of Daejeon University)
  • 최병렬 (대전대학교부속 한방병원 간계내과학교실) ;
  • 이용연 (대전대학교부속 한방병원 간계내과학교실) ;
  • 유화승 (대전대학교부속 한방병원 간계내과학교실) ;
  • 서상훈 (대전대학교부속 한방병원 간계내과학교실) ;
  • 최우진 (대전대학교부속 한방병원 간계내과학교실) ;
  • 조정효 (대전대학교부속 한방병원 간계내과학교실) ;
  • 이연월 (대전대학교부속 한방병원 간계내과학교실) ;
  • 손창규 (대전대학교부속 한방병원 간계내과학교실) ;
  • 조종관 (대전대학교부속 한방병원 간계내과학교실) ;
  • 송기철 (대전대학교부속 한방병원 간계내과학교실)
  • Published : 2001.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: The purpose of this study was to examine the efficacy of Hangamdan(Kangaidan) on 60 patients who have suffered from breast cancer. Methods: Hangamdan(Kangaidan) was administered to patients for over 1 months continuously. We checked improvement of clinical symptoms, changes of chemistry hematological test. Results: The results obtained are summarized as follows. Hangamdan(Kangaidan) has significant effect on the improvement of clinical symptoms. The effects of maintenance and improvement in the symptoms with traditional oriental therapy(83.3%) and combined treatment of western and oriental therapy(92.1%) were observed. The effects of the symptoms were diarrhea(37.3%), abdominal pain (25.3%), general body weakness(22.9%), nausea(20.5%) and etc. in orders. And analysis of hematology attached by breast cancer, maintenance and increasing of WBC(89.9%), RBC(74.7%), Hgb(81.1%), Platelet(92.4%) were observed. After taken Hangamdan(Kangaidan), maintenance and decreasing of AST(85.9%), ALT(94.8%), ${\gamma}$-GTP(87.5%), BUN(88.3%), Creatinine(90.9%) were observed. And increasing of IL-12(25%), IFN-${\gamma}$(83%) were observed. Conclusions: From the above results, it is suggested that Hangamdan(Kangaidan) have significant effects on recovery of immune modulation.

Keywords

References

  1. 한방임상종양학 趙鍾寬
  2. J Korean Med Assoc v.35 no.4 Systemic treatment of breast cancer Bang, Y.J.;Kim, N.K,
  3. Cancer, Principles and Practice of Oncology Cancer of the breasr Harris, J.;Morrow, M.;Norton, L.;Devita, V.T.Jr.(ed.);Hellma, S.(ed.);Rosenberg, S.A.(ed.)
  4. N Engl J Med v.317 Improving the quality of life during chemotherapy for advanced breast cancer;A comparison of intermittent and continuous treatment strategies Coates, A.;Gebeski, V.;Bishop, J.F.;Jeal, P.N.;Woods, R.L.;Snyder, R.;Tattersall, M.H.;Byrne, M.;Harvey, V.;Gill, G.
  5. Br J Cancer v.74 A multicentre phase II study of docetaxel 75mg m-2 as first-line chemotherapy for the Clinecal Screening Group of the EORTC Dieras, V.;Chevallier, B.;Kerbrat, P.;Krakowski, I.;Roche, H.;Misset, J.L.;Lentz, M.A.;Azli, N.;Murawsky, M.;Riva, R.;Pouilart, P.;Fumoleau, P.
  6. Semin Oncol v.24 Introduction: taxoids and the management of breast cancer Hortobagyi, G.N.
  7. 實用中西醫結合雜誌 v.11 no.8 乳腺癌化療後毒副反應觀察及中西醫治療與護理 陳英(외1인)
  8. 河北中西醫結合雜誌 v.7 no.1 233例乳腺癌術後常見倂發症及基豫防的分析 宋全(외2인)
  9. 大田大學敎 大學院 碩士學位論文 抗癌丹을 投與한 各種 癌患者 320例에 對한 考察 曺政孝
  10. 韓方病院處方集 大田大學敎 韓方病院
  11. Ministry of Health and Welfare Cancer Registry Programe in the Republic of Korea
  12. J Korean Surg Soc v.55 Korean breast cancer data of 1996 Korean Breasr Cancer Study Group
  13. J Korean Surg Soc v.55 A clinical study of breast cancer Jung, N.Y.;Cho, B.S.;Kang, Y.J.
  14. J Korean Surg Soc v.48 A clinical study and late results of breast cancer Jeon, H.K.;Lee, C.H.;Choi, H.K.;Lee, S.D.;Park, Y.H.
  15. J Korean Surg Soc v.42 A clinical analysis of breast cancer Hwang, S.H.;Lee, J.Y.;Kim, S.H.
  16. J Korean Surg Soc v.54 Changes in the clinical reatures of and the treatment for breast cancer Noh, D.Y.;Kim, H.S.;Youn, Y.K.;Oh, S.K.;Choe, K.J.
  17. Korean J Intern Med v.34 no.6 Combination chemotherapy with cyclophosphamide, adriamycin, methotrexate and 5-fluorouracil for metastatic breast cancer Kim, S.Y.;Kim, H.T.;Kang, Y.K.;Suh, C.W.;Bang, Y.J.;Kim, N.K.
  18. J Korean Cancer Res Assoc v.26 no.1 Second-line chemotherapy with cyclophospahmide, adraamycin, 5-fluorourackl, vincristine, and prednisolone for advanced breast cancer Chang, H.M.;Kim, H.A.;Kim, W.S.;Heo, D.S.;Bang, Y.J.;Kim, N.K.
  19. J Clin Oncol v.9 Adjuvant chemotherapy with doxorubicin plus cyclopho-sphamide, methotrexate, and fluorouracil in the treatment of rasectable breast cancer with more than three positive axillary nodes Buzzoni, R.;Bonadonna, G.;Valagussa, P.;Zambetti, M.
  20. J Korean Cancer Res Assoc v.26 no.1 Second-line chemotherapy with cyclophospahmide, adraamycin, 5-fluorourackl, vincristine, and prednisolone for advanced breast cancer Chang, H.M.;Kim, H.A.;Kim, W.S.;Heo, D.S.;Bang, Y.J.;Kim, N.K.
  21. 충남대학교 대학원 박사학위논무 소화기암 세포주에 대한 Interferon의 항암제 세포독성 증강효과 김성철
  22. 東醫腫瘍學 최승훈
  23. 常見腫瘤診治指南 孫奎芝
  24. 實用中西醫結合診斷治療學 陳貴延
  25. 中藥癌症治療學 鄧榮坤
  26. 抗癌本草 常敏毅
  27. 抗癌藥膳 常敏毅
  28. 申氏本草學(各論) 申佶求
  29. 漢藥臨床應用 李尙仁(외)
  30. 韓國藥用植物圖鑑 陸昌洙